silence-therapeutics.com (SLN) - Pendapatan dodolan perusahaan

Lambang korporat lan logo Silence Therapeutics plc (SLN)

Silence Therapeutics is integrating ESG principles into RNA therapeutics, strictly adhering to bioethics and environmental sustainability. The technical state of the laboratories allows for the efficient scaling of drug synthesis. The company's current sales volume demonstrates revenue dynamics, where the indicator stands at 0.00, helping to avoid purchasing the asset at its peak. Meanwhile, production and clinical trials have been delegated to external contract partners.

SLN Silence Therapeutics Corp: Pendapatan perusahaan ing interval 21.06.2023 - 17.11.2026

Rincian analitis perusahaan Silence Therapeutics

- rega saham lan konsensus proyeksi valuasi:
Ringkesan analisis perusahaan:SLN (Silence Therapeutics plc)
Barang utama silence-therapeutics.com

Silence Therapeutics (SLN) sales reflect a net revenue stream without quarterly window dressing, allowing for the differentiation of speculative growth from fundamental business resilience. In the case of Silence Therapeutics (SLN), this trend is confirmed by the effective implementation of ESG standards in RNA therapeutics and the optimization of laboratory costs. Close monitoring of Silence Therapeutics (SLN) sales reveals the actual pace of monetization for bioethical innovations. This indicator serves as a measure of the issuer's operational viability, and investors should utilize it to assess the strategic preservation of capital.

Perusahaan pesaing

Tempus AI, Inc. (TEM) - Pendapatan reged perusahaan|Dodolan perusahaan QGEN (Qiagen NV)|Pendapatan lan volume dodolan Ionis Pharmaceuticals, Inc. (IONS)|Pendapatan lan volume dodolan RGEN (Repligen Inc.)|Avidity Corp (RNA) - Total pendapatan perusahaan|CRSP - Pendapatan perusahaan|Pendapatan reged perusahaan genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Pendapatan perusahaan|Total pendapatan perusahaan Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Twist Bioscience Corp TWST|Pendapatan lan volume dodolan TXG|Pendapatan lan volume dodolan intelliatx.com (NTLA)|Stoke Therapeutics - Dodolan perusahaan|BioLife Solutions Inc (BLFS) - Total pendapatan perusahaan|wavelifesciences.com - Pendapatan lan volume dodolan|Maze Therapeutics Corp (MAZE) - Dodolan perusahaan|SION: Pendapatan lan volume dodolan|Volume dodolan perusahaan PRME|Pendapatan perusahaan Taysha Gene Therapies|Volume dodolan perusahaan QURE (uniQure)|Pendapatan perusahaan MeiraGTx (MGTX)|REGENXBIO Corp - Volume dodolan perusahaan|Pendapatan perusahaan Solid Biosciences SLDB|OCGN - Dodolan perusahaan|pacb.com - Pendapatan lan volume dodolan|Benitec (BNTC) - Dodolan perusahaan|DSGN: Pendapatan lan volume dodolan|RCKT - Pendapatan reged perusahaan|FDMT: Pendapatan reged perusahaan|Volume dodolan perusahaan LXEO (lexeotx.com)|Pendapatan perusahaan Korro Bio Inc. (KRRO)|Total dodolan perusahaan EDIT|Pendapatan perusahaan ProQR Therapeutics N.V. PRQR|Pendapatan reged perusahaan Codexis, Inc. (CDXS)|SGMO - Pendapatan perusahaan|nautilus.bio - Total dodolan perusahaan|Metagenomi, Inc (MGX) - Pendapatan perusahaan|Volume dodolan perusahaan DTIL|Pendapatan perusahaan Generation Bio|Pendapatan lan volume dodolan Boundless Bio Inc|Pendapatan perusahaan Exicure Corp (XCUR)|Pendapatan reged perusahaan Imunon|Pendapatan lan volume dodolan PHIO (phiopharma.com)|Total volume dodolan perusahaan mustangbio.com|RNAZ - Pendapatan perusahaan|Total pendapatan perusahaan Bionano Genomics|APDN: Pendapatan lan volume dodolan|Volume dodolan perusahaan BLUE|Dodolan perusahaan IPA|OMGA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan OMIC|Pendapatan reged perusahaan Regulus Therapeutics|Pendapatan perusahaan Syros SYRS|Pendapatan dodolan perusahaan TBIO|TCON: Dodolan perusahaan|Unity Biotechnology, Inc. (UBX) - Dodolan perusahaan